Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2020

Feb 27, 2020

33153_dirs_2020-02-27_082385d9-9a46-40ae-8b16-e2484d4459ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO (MLAB)
CIK: 0000724004
Period of Report: 2020-02-25

Reporting Person: Sullivan John James (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-25 Common Stock M 6000 $50.5 Acquired 77347 Direct
2020-02-25 Common Stock M 2206 $51.85 Acquired 79553 Direct
2020-02-25 Common Stock S 8206 $267.09 Disposed 71347 Direct
2020-02-26 Common Stock M 100 $51.85 Acquired 71447 Direct
2020-02-26 Common Stock M 970 $89.7 Acquired 72417 Direct
2020-02-26 Common Stock S 1070 $263.39 Disposed 71347 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-25 Non Qualified Stock Option $50.5 X 6000 Disposed 2022-04-02 Common Stock (6000) Direct
2020-02-25 Non Qualified Stock Option $51.85 X 2206 Disposed 2023-04-01 Common Stock (2206) Direct
2020-02-26 Non Qualified Stock Option $51.85 X 100 Disposed 2023-04-01 Common Stock (100) Direct
2020-02-26 non Qualified Stock Option $89.7 X 970 Disposed 2022-04-01 Common Stock (970) Direct

Footnotes

F1: 25% Exercisable on each anniversary of the 4-2-13 grant date

F2: 25% exercisable on each anniversary date of the 4-1-13 grant date

F3: 1/7 exercisable each anniversary date of the 4-1-14 grant date